Vestibular migraine
Diagnosis and treatment of vestibular migraine.
Papers per year
Each bar is 12 months; the last one ends 17 Oct 2026. New trials in the same years: 5, 3, 3, 6, 13.
All papers from the last 12 months
177 papers (18 Oct 2025 – 17 Oct 2026), newest first. Loading the full list…
- Mechanisms of neuroimmune crosstalk in vestibular disorders: Linking inflammation with neural circuit dysfunction (Review)Int J Mol Med2026 DecPMID 42852636Review
- The Auxiliary Diagnostic Value of Microsaccades in Vestibular MigraineLaryngoscope2026 NovPMID 42337838
- Identifying potential risk factors for migraine-related vertigo in childrenInt J Pediatr Otorhinolaryngol2026 Oct 13PMID 42868945
- Depressive and Anxiety Symptoms in Vestibular Migraine and Probable Vestibular MigraineClin Otolaryngol2026 Oct 11PMID 42860634
- Distinguishing Meniere's disease from vestibular migraine: A comprehensive review of symptoms and diagnostic insightsJ Int Med Res2026 OctPMID 42816771Review
- Visual, vestibular, and ocular motor changes during nitroglycerin-triggered vestibular migraineHeadache2026 OctPMID 42698392
- Identifying central positional vertigo to prevent diagnostic pitfalls: A case series and review of literatureRadiol Case Rep2026 OctPMID 42564662
- Differentiating Ménière Disease and Vestibular Migraine: A Prospective MRI Study of Endolymphatic HydropsOtol Neurotol2026 Oct 1PMID 42456062
- [Diagnosis and treatment of vestibular migraine - recent developments and future treatment strategies]Laryngorhinootologie2026 OctPMID 42335970Review
- Redefining Disease Classification and Teaching in OtolaryngologyOtolaryngol Head Neck Surg2026 Sep 29PMID 42808696
More otorhinolaryngology trends
All specialties →Biologics for nasal polyps
Dupilumab and other biologics for chronic rhinosinusitis with nasal polyps.
Gene therapy for hearing loss
Gene therapy for genetic deafness, such as OTOF mutations.
Hearing loss and dementia
Hearing loss, hearing aids and cognitive decline.
Hypoglossal nerve stimulation
An implanted stimulator for obstructive sleep apnoea.
Key point: In France, hypoglossal nerve stimulation is indicated for non-obese moderate-to-severe OSAHS patients with CPAP or MAD failure or contraindications after mandatory DISE.
Tinnitus
Tinnitus mechanisms and treatments, including neuromodulation.
Cochlear implants
Cochlear implantation, including in older adults and single-sided deafness.
Key point: Cochlear implant indications now include profound unilateral or bilateral sensorineural hearing loss, unilateral deafness, or residual hearing, determined individually for each ear.
Too many papers to read?
PubDaily picks the ones that matter in your specialty and summarises them, about 10 minutes a week.
How these numbers are counted
PubMed query, searched in titles and abstracts by publication date:
"vestibular migraine"[tiab]Trials: ClinicalTrials.gov studies first submitted in each 12-month window that match the same terms. A query can miss synonyms or catch unrelated papers, so treat counts as approximate.